News
BAX
30.62
+0.39%
0.12
Baxter International To Present At J.P. Morgan Healthcare Conference; Webcast At 1:30 PM ET
NASDAQ · 1d ago
Weekly Report: what happened at BAX last week (0106-0110)?
Weekly Report · 2d ago
Weekly Report: what happened at BAX last week (1230-0103)?
Weekly Report · 01/06 09:20
Puerto Rico Blackout: 8 Stocks Affected By Island-Wide Power Outage
Benzinga · 12/31/2024 16:42
Investors in Baxter International (NYSE:BAX) have unfortunately lost 64% over the last three years
Simply Wall St · 12/31/2024 12:07
Weekly Report: what happened at BAX last week (1223-1227)?
Weekly Report · 12/30/2024 09:19
ILCV's Holdings Could Mean 12% Gain Potential
NASDAQ · 12/26/2024 12:49
How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks?
Barchart · 12/26/2024 08:14
How Is The Market Feeling About Baxter Intl?
Benzinga · 12/24/2024 17:45
Weekly Report: what happened at BAX last week (1216-1220)?
Weekly Report · 12/23/2024 09:20
Early notable gainers among liquid option names on December 20th
TipRanks · 12/20/2024 14:55
Interesting BAX Put And Call Options For August 2025
NASDAQ · 12/19/2024 15:44
Worst performing stocks for tax loss selling – Wolfe
Seeking Alpha · 12/16/2024 19:59
Weekly Report: what happened at BAX last week (1209-1213)?
Weekly Report · 12/16/2024 09:21
Baxter Stock May Gain Following Five New Injectable Product Launches
NASDAQ · 12/13/2024 15:20
Baxter International Is Maintained at Neutral by Citigroup
Dow Jones · 12/11/2024 19:12
Baxter International Price Target Cut to $35.00/Share From $37.00 by Citigroup
Dow Jones · 12/11/2024 19:12
Citigroup Maintains Neutral on Baxter Intl, Lowers Price Target to $35
Benzinga · 12/11/2024 19:03
Baxter price target lowered to $35 from $37 at Citi
TipRanks · 12/11/2024 11:46
Oversold Conditions For Baxter International (BAX)
NASDAQ · 12/10/2024 18:34
More
Webull provides a variety of real-time BAX stock news. You can receive the latest news about Baxter Intl Inc through multiple platforms. This information may help you make smarter investment decisions.
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.